Avecho Biotechnology Limited (OEZ) - Total Liabilities

Latest as of December 2024: €1.73 Million EUR ≈ $2.02 Million USD

Based on the latest financial reports, Avecho Biotechnology Limited (OEZ) has total liabilities worth €1.73 Million EUR (≈ $2.02 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Avecho Biotechnology Limited operating cash flow efficiency to assess how effectively this company generates cash.

Avecho Biotechnology Limited - Total Liabilities Trend (2013–2024)

This chart illustrates how Avecho Biotechnology Limited's total liabilities have evolved over time, based on quarterly financial data. Check Avecho Biotechnology Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Avecho Biotechnology Limited Competitors by Total Liabilities

The table below lists competitors of Avecho Biotechnology Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Cyclerion Therapeutics Inc NASDAQ:CYCN	USA	$900.00K
Smith Micro Software Inc NASDAQ:SMSI	USA	$7.24 Million
Zantat Holdings Berhad KLSE:0301	Malaysia	RM28.33 Million
Pursuit Minerals Ltd AU:PUR	Australia	AU$635.60K
Orissa Bengal Carrier Limited NSE:OBCL	India	Rs712.23 Million
Energous Corporation NASDAQ:WATT	USA	$4.11 Million
Property Perfect Public Company Limited BK:PF	Thailand	฿32.61 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Avecho Biotechnology Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Avecho Biotechnology Limited market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.53	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avecho Biotechnology Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avecho Biotechnology Limited (2013–2024)

The table below shows the annual total liabilities of Avecho Biotechnology Limited from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	€1.73 Million ≈ $2.02 Million	+83.43%
2023-12-31	€941.54K ≈ $1.10 Million	+2.27%
2022-12-31	€920.66K ≈ $1.08 Million	+29.79%
2021-12-31	€709.36K ≈ $829.32K	+1.31%
2020-12-31	€700.17K ≈ $818.57K	+25.90%
2019-12-31	€556.12K ≈ $650.17K	-38.35%
2018-12-31	€902.04K ≈ $1.05 Million	-50.87%
2017-12-31	€1.84 Million ≈ $2.15 Million	+7.57%
2016-12-31	€1.71 Million ≈ $2.00 Million	-6.00%
2015-12-31	€1.82 Million ≈ $2.12 Million	-3.04%
2014-12-31	€1.87 Million ≈ $2.19 Million	-14.36%
2013-12-31	€2.19 Million ≈ $2.56 Million	--

About Avecho Biotechnology Limited

F:OEZ Germany Biotechnology

Market Cap

$25.77 Million

€22.04 Million EUR

Market Cap Rank

#26309 Global

#2267 in Germany

Share Price

€0.01

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.01

All Time High

€0.03